Reading disease one cell at a time
Oncoptic pairs advanced optical technology with artificial intelligence to analyze individual cells — bringing earlier, more precise detection to blood cancer and beyond.
A new generation of medical analysis — precise, data-driven, and personalized.
Today’s diagnostics miss what happens inside the cell
Current approaches provide valuable information, but critical challenges remain.
Cellular blind spots
Limited understanding of individual cellular differences.
Detection comes late
The need for more precise and earlier disease detection persists.
Complex workflows
Diagnostic pipelines are slow, fragmented, and hard to scale.
Hard to monitor
Tracking disease progression and treatment response remains difficult.
An optical + AI platform for single-cell insight
Oncoptic combines innovative optical technologies with artificial intelligence to extract meaningful biological information from individual cells.
Identify cellular change
Detect the subtle cellular signatures associated with disease.
Distinguish behavior
Differentiate healthy and abnormal cellular behavior with precision.
Faster, accurate diagnostics
Support quicker and more reliable diagnostic decisions.
Powered by AI
Machine learning turns optical signals into actionable biological insight.
Single-cell resolution
Analyze biology at the level of the individual cell.
Built for what’s next
Enable future applications in personalized medicine and therapeutic monitoring.
A laboratory-grade instrument, reimagined
Our platform radically reduces the cost of discovering and validating novel diagnostics — making it feasible to develop screening tests for diseases that previously had none.
Why it matters
The team
Scientists and engineers from MIT, Harvard, Columbia, and leading industry labs.
Latest news
Milestones and announcements from Oncoptic.
Let’s redefine early detection together
Whether you’re a clinician, researcher, investor, or potential teammate — we’d love to talk.
Get in touch